Table 4. Association between renal impairment and death or non-optimal neurodevelopmental outcomes in the validation set.
Odds ratio | 95% CI |
p-value
|
||
---|---|---|---|---|
HSCr > critical values as risk factor for death (n=976) | ||||
No adjustment | 11.2 | (6.9; 18.2) | 0.001 | |
Adjustment for GA, birth weight Z-score and sex | 8.6 | (5.0 ; 14.6) | 0.001 | |
Adjustment for GA, birth weight Z-score, sex and risk factors for HSCr > critical values | 9.3 | (4.7 ; 18.7) | 0.001 | |
Adjustment for GA, birth weight Z-score, sex, risk factors for HSCr > critical values and diuretic treatment | 9.5 | (4.7 ; 19.1) | 0.001 | |
Adjustment for GA, birth weight Z-score, sex, risk factors for HSCr > critical values, diuretic treatment and delta natremia | 8.8 | (4.3 ; 17.8) | 0.001 | |
HSCr> critical values as risk factor for Non optimal Outcome (n=729) | ||||
No adjustment | 2.1 | (1.3 ; 3.4) | 0.004 | |
Adjustment for GA, birth weight Z-score and sex | 1.9 | (1.2 ; 3.1) | 0.013 | |
Adjustment for GA, birth weight Z-score, sex and risk factors for HSCr > critical values | 1.7 | (0.97 ; 2.9) | 0.063 | |
Adjustment for GA, birth weight Z-score, sex, risk factors for HSCr > critical values and diuretic treatment, | 1.7 | (0.97 ; 2.9) | 0.062 | |
Adjustment for GA, birth weight Z-score, sex, risk factors for HSCr > critical values, diuretic treatment and delta natremia | 1.5 | (0.85 ; 2.6) | 0.16 |
Abbreviations: HSCr, highest serum creatinineCritical values: 1.6 mg/dL at 24-27 weeks, 1.1 mg/dL at 28-29 weeks, and 1.0 mg/dL at 30-32 weeks)